1Sravani PV,Babu NK,Gopal K,et al.Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin.Indian J Dermatol Venereol Leprol,2009,75:268-271.
2Sehgal VN,Srivastava G.Vitiligo:Compendium of clinico-epidemiological features.Indian J Dermatol Venereol Leprol,2007,73:149-156.
3Denman CJ,McCracken J,Hariharan V,et al.HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo.J Invest Dermatol,2008,128(8):2041-2048.
4Gauthier Y,Cario AM,Taieb.A critical appraisal of vitiligo etiologic theories is melanocyte loss a melanocytorrhagy? PigmentCell-Res,2004,(17):322-332.
5Boissy RE,Manga P.On the etiology of contact/occupational vitiligo.Pigment Cell Res,2004,17(3):208-214.
6Spritz RA,Gowan K,Bennett DC,et al.Novel vitiligo susceptibility loci on chromosome 17,and their roles in an autoimmune diathesis.Am J Hum Genet,2004,74(1):188-191.
7Nath SK,Kelly JA,Namjou B,et al.Evidence for a susceptibility gene,SLEV1,on chromosome 17p13 in families with vitiligo -related systemic lupus erythematosus.Am J Hum Genet,2001,69(6):1401-1406.
8De Vijlder HC,Westerhof W,Schreuder GM,et al.Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study.Pigment Cell Res,2004,17:270-274.
9Ren Y,Yang S.Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo.PLoS Genet,2009,5(6):e1000523.
8Chang CY, Lee J, Kim EY, et al. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Thl response in a mouse hepatic cancer model. BMC Cancer, 2007, 23 (7) :87-87.
9Jin LQ, Zheng ZJ, Peng Y, et al. Opposite effects on tumor growth depending on dose of Achyranthes bidentata polysaccharides in C57BL/6 mice. Int Immunopharmacol, 2007, 7(5) :568-577.
10Yun A J, Lee PY. The link between T helper balance and lymphoproliferative disease. Med Hypotheses ,2005,65 ( 3 ) :587-590.
